If your current treatment is causing symptoms such as nausea, diarrhoea, constipation, or vomiting, and these become difficult to manage in your daily life, it may be worth considering a switch, as you could find the other medication easier to live with
Patients using Tirzepatide have reported significant reductions in HbA1c
Its important to point out that Wegovy is now approved for those who already have cardiovascular disease and who have obesity or overweight
Suppose youre interested in exploring the potential benefits of BPC-157 or other peptides for tissue repair and regeneration
Cagrilintide is a synthetic, long-acting amylin analogue developed by Novo Nordisk
Brightmeds provides compounded tirzepatide at $1,191 per quarter or $499 per month, with a $200 first-order discount